28262 Federal Register / Vol. 74, No. 113 / Monday, June 15, 2009 / Notices 

Date: July 20–21, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Cathleen L. Cooper, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, 301–435– 

3566, cooperc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; NCSD 

Competitive Revisions. 

Date: July 21–22, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Alexandra M. Ainsztein, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5144, 

MSC 7840, Bethesda, MD 20892, 301–451– 

3848, ainsztea@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; 

Fellowships: Physiology and Pathobiology of 

Cardiovascular and Respiratory Systems. 

Date: July 22, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: AVENUE Hotel Chicago, 160 E 

Huron, Chicago, IL 60611. 

Contact Person: Abdelouahab Aitouche, 

PhD, Scientific Review Officer, Center of 

Scientific Review, RKLG I, Room 2188, 6701 

Rockledge Drive, Bethesda, MD 20892, 301– 

435–2365, aitouchea@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; FlowCytometry. 

Date: July 23–24, 2009. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Alessandra M. Bini, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5142, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1024, binia@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Infectious 

Agent and Toxin Detection, Disinfection and 

Bioremediation. 

Date: July 24, 2009. 

Time: 8:30 a.m. to 10 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Richard G. Kostriken, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–402– 

4454, kostrikr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; 

Microbiology Member Conflicts. 

Date: July 24, 2009. 

Time: 9 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: John C. Pugh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2398, pughjohn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Roadmap 

HTS Assay for MLPCN. 

Date: July 30, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel & Executive 

Meeting Center, 8120 Wisconsin Avenue, 

Bethesda, MD 20814. 

Contact Person: James J. Li, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5148, MSC 7849, Bethesda, MD 

20892, 301–435–2417, lijames@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Small 

Business—Respiratory Sciences. 

Date: July 30–31, 2009. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Ghenima Dirami, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4112, 

MSC 7814, Bethesda, MD 20892, 301–594– 

1321, diramig@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 8, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13939 Filed 6–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the National Center for 

Research Resources Special Emphasis 

Panel, July 20, 2009, 8 a.m. to July 24, 

2009, 5 p.m., National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Bethesda, MD 

20892 which was published in the 

Federal Register on May 27, 2009, 74 

FR 25262. 

The previously published July 20–24, 

2009, meeting has been changed to a 

one day meeting on July 24, 2009. The 

meeting is closed to the public. 

Dated: June 8, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13950 Filed 6–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Acquired Immunodeficiency 

Syndrome Research Review Committee. 

Date: July 13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Hotel and EMC, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: Erica L. Brown, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–451–2639, 

ebrown@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 74, No. 113 / Monday, June 15, 2009 / Notices 28263 

Dated: June 8, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13949 Filed 6–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; CF Center 

Competitive Revisions. 

Date: July 29, 2009. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call) 

Contact Person: Michele L. Barnard, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 753, 6707 Democracy Boulevard, 

Bethesda, MD 20892–2542, (301) 594–8898, 

barnardm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research; 93.701, ARRA 

Related Biomedical Research and Research 

Support Awards, National Institutes of 

Health, HHS) 

Dated: June 8, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13940 Filed 6–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2009–0087] 

The Critical Infrastructure Partnership 

Advisory Council (CIPAC) 

AGENCY: National Protection and 

Programs Directorate, DHS. 

ACTION: Update of CIPAC council 

membership. 

SUMMARY: The Department of Homeland 

Security (DHS) announced the 

establishment of the Critical 

Infrastructure Partnership Advisory 

Council (CIPAC) by notice published in 

the Federal Register Notice (71FR 

14930–14933) dated March 24, 2006. 

That notice identified the purpose of 

CIPAC as well as its membership. This 

notice provides (i) the quarterly CIPAC 

membership update, (ii) instructions on 

how the public can obtain the CIPAC 

membership roster and other 

information on the Council, and (iii) 

information on recently completed 

CIPAC meetings. 

FOR FURTHER INFORMATION CONTACT: 

Nancy Wong, Director Partnership 

Programs and Information Sharing 

Office, Partnership and Outreach 

Division, Office of Infrastructure 

Protection, National Protection and 

Programs Directorate, United States 

Department of Homeland Security, 

Washington, DC 20528, telephone (703) 

235–3999 or via e-mail at 

CIPAC@dhs.gov. 

Responsible DHS Official: Nancy J. 

Wong, Director Partnership Programs 

and Information Sharing Office, 

Partnership and Outreach Division, 

Office of Infrastructure Protection, 

National Protection and Programs 

Directorate, United States Department of 

Homeland Security, Washington, DC 

20528, telephone (703) 235–3999 or via 

e-mail at CIPAC@dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose and Activity: CIPAC 

facilitates interaction between 

government officials and representatives 

of the community of owners and/or 

operators for each of the critical 

infrastructure or key resource (CIKR) 

sectors defined by Homeland Security 

Presidential Directive 7 (HSPD–7) and 

identified in the National Infrastructure 

Protection Plan (NIPP). The scope of 

activities covered by CIPAC includes 

planning; coordinating among 

government and CIKR owner/operator 

security partners; implementing security 

program initiatives; conducting 

operational activities related to critical 

infrastructure protection security 

measures, incident response, recovery, 

infrastructure resilience, reconstituting 

CIKR assets and systems for both manmade as well as naturally occurring 

events; and sharing threat, vulnerability, 

risk mitigation, and infrastructure 

continuity information and best 

practices. 

Organizational Structure: CIPAC 

members are organized into eighteen 

HSPD–7 critical infrastructure and/or 

key resource sectors. Within all of the 

sectors containing private sector CIKR 

owners/operators there generally exists 

a Sector Coordinating Council (SCC) 

that includes CIKR owners and/or 

operators or their representative trade 

associations. Each of the sectors also has 

a Government Coordinating Council 

(GCC) whose membership includes a 

lead Federal agency that is defined as 

the Sector Specific Agency (SSA), and 

all of the relevant Federal, State, local, 

Tribal, and/or Territorial government 

agencies (or their representative bodies) 

whose mission interests also involve the 

scope of the CIPAC activities for that 

particular sector. 

CIPAC Membership: CIPAC 

Membership includes (i) CIKR owner 

and/or operator members of an SCC; (ii) 

trade association members who are 

members of a SCC representing the 

interests of CIKR owners and/or 

operators. CIKR owners and operators 

own and invest in infrastructure assets 

or in the systems and processes to 

secure them. CIKR owners and/or 

operators are held responsible by the 

public for CIKR operations and the 

response and recovery when their CIKR 

assets and systems are disrupted; (iii) 

each sector’s Government Coordinating 

Council (GCC); and, based upon DHS’ 

recent establishment of this council; (iv) 

State, local, Tribal, and Territorial 

governmental officials comprising the 

DHS State, local, Tribal, Territorial GCC. 

CIPAC Membership Roster and 

Council Information: The current roster 

of CIPAC membership is published on 

the CIPAC Web site (http:// 

www.dhs.gov/cipac) and is updated as 

the CIPAC membership changes. 

Members of the public may visit the 

CIPAC Web site at any time to obtain 

current CIPAC membership as well as 

the current and historic list of CIPAC 

meetings and agendas. 

Dated: June 1, 2009. 

Nancy Wong, 

Designated Federal Officer for the CIPAC. 

[FR Doc. E9–13887 Filed 6–12–09; 8:45 am] 

BILLING CODE 9110–9P–P 


pwalker on PROD1PC71 with NOTICES